1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine
C22H26F2N6 — CID 139297585
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine
1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine (PubChem CID 139297585) has the molecular formula C22H26F2N6 and a molecular weight of 412.49 g/mol. Its IUPAC name is 1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine.
Molecular Properties
| Compound Name | 1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine |
|---|---|
| PubChem CID | 139297585 |
| Molecular Formula | C22H26F2N6 |
| Molecular Weight | 412.49 g/mol |
| Exact Mass | 412.22 |
| IUPAC Name | 1-(3,4-difluorophenyl)-N-[3-methyl-5-(4-propan-2-ylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-amine |
| SMILES | Cc1cc(Nc2ncn(-c3ccc(F)c(F)c3)n2)cc(N2CCN(C(C)C)CC2)c1 |
| InChI | InChI=1S/C22H26F2N6/c1-15(2)28-6-8-29(9-7-28)19-11-16(3)10-17(12-19)26-22-25-14-30(27-22)18-4-5-20(23)21(24)13-18/h4-5,10-15H,6-9H2,1-3H3,(H,26,27) |
| InChIKey | ZWAFNWRESOGHRL-UHFFFAOYSA-N |
| XLogP | 4.13 |
| TPSA | 49.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.49 |
| LogP ≤ 5 | 4.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139297585 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.